KAL1 anticorps (Center)
Aperçu rapide pour KAL1 anticorps (Center) (ABIN783480)
Antigène
Voir toutes KAL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Center
-
Specificité
- This antibody detects Anosmin (Center).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Affinity chromatography
-
Immunogène
- Raised against an 18 amino acid peptide near the center of human Anosmin
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Autre désignation
- Anosmin-1
-
Sujet
- Mutations in Anosmin-1, an extracellular matrix-associated glycosylated protein, have been linked with Kallmann Syndrome (KS), an X-linked genetic disorder characterized by loss of smell caused by abnormal olfactory bulb development and delayed puberty caused by disrupted migration of the gonadotropin-releasing hormone neuron. Anosmin-1 has been shown to directly bind FGFR1 via its N-terminal cysteine-rich domain, whey-acidic protein-like domain, and its first FnIII repeat with the D2 and D3 ectodomains of FGFR1. It is thought that Anosmin-1 can modulate FGFR1 signaling and have opposing effects on the formation and activation of FGF2-FGFR1-heparing complex.Synonyms: ADMLX, Adhesion molecule-like X-linked, KAL, KAL1, KALIG1, Kallmann syndrome protein
-
ID gène
- 3730
-
NCBI Accession
- NP_000207
-
UniProt
- P23352
Antigène
-